Attention-Deficit/Hyperactivity Disorder (ADHD) Market to Witness Upsurge in Growth During the Forecast Period (2023-32), Examine DelveInsight | Otsuka, BioLite, RespireRx, KemPharm, Ensysce, Cingulate

DelveInsight's "Attention-Deficit/Hyperactivity Disorder Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Attention-Deficit/Hyperactivity Disorder Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Attention-Deficit/Hyperactivity Disorder therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Attention-Deficit/Hyperactivity Disorder treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Attention-Deficit/Hyperactivity Disorder (ADHD): An Overview
Attention-deficit/hyperactivity disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. It is a group of behaviors and is also called as attention deficit disorder (ADD). It is a behavioral disorder that includes symptoms such as inattentiveness, hyperactivity, and impulsiveness.

The exact cause of ADHD is still not known. Like many other illnesses, several factors can contribute to ADHD, such as genes, cigarette smoking, alcohol use, or drug use during pregnancy, exposure to environmental toxins during pregnancy, exposure to environmental toxins, such as high levels of lead, at a young age, low birth weight or brain injuries. Diagnosing ADHD in children depends on a set of strict criteria. To be diagnosed with ADHD, pediatric patients must have 6 or more symptoms of inattentiveness, or 6 or more symptoms of hyperactivity and impulsiveness.

Attention-Deficit/Hyperactivity Disorder (ADHD) Market Key Facts
• The Centers for Disease Control and Prevention (CDC) suggests that according to a national 2016 parent survey, the estimated number of children (3-17 years) diagnosed with ADHD was 6.1 million (9.4%). This number includes 388,000 children aged 2-5 years, 4 million children aged 6-11 years, and 3 million children aged 12-17 years. Furthermore, the CDC also highlights the fact that boys are more likely to be diagnosed with ADHD than girls (12.9% compared to 5.6%).
• As per Göbel et al. (2018), overall 4.4% of children and adolescents between 3 and 17 years of age were diagnosed of ADHD by a physician or psychologist at KiGGS Wave 2 (2014-2017). As per this study 2.3% of females and 6.5% males had ADHD.
• As per Moffitt et al. (2007), the North American prevalence rate (6.2%) only slightly exceeded the European prevalence rate (4.6%) for ADHD.
• According to a study conducted by Riedel et al. (2021), across all data years, age- and sex-standardized prevalence of ADHD ranged between 37.2/1,000 (2009) and 43.5/1,000 (2015).

Attention-Deficit/Hyperactivity Disorder (ADHD)Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Attention-Deficit/Hyperactivity Disorder therapies in the market. It also provides a detailed assessment of the Attention-Deficit/Hyperactivity Disorder market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Attention-Deficit/Hyperactivity Disorder drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Discover How Attention-Deficit/Hyperactivity Disorder Market will Grow by 2032:
https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Attention-Deficit/Hyperactivity Disorder (ADHD) Epidemiology
The epidemiology section covers detailed insights into the historical, and current Attention-Deficit/Hyperactivity Disorder patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Attention-Deficit/Hyperactivity Disorder (ADHD) Epidemiology Segmented as -
• Total Diagnosed Prevalent Cases of Attention Deficit Hyperactivit Disorder (ADHD) in the 7MM [2019-2032]
• Subtype-specific Diagnosed Prevalent Cases of Attention Deficit Hyperactivity Disorder (ADHD) in the 7MM [2019-2032]
• Gender-specific Diagnosed Prevalent Cases of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in the 7MM [2019-2032]
• Gender-specific Diagnosed Prevalent Cases of Attention Deficit Hyperactivity Disorder (ADHD) in Children in the 7MM [2019-2032]

Get Key Insights Into the Evolving Attention-Deficit/Hyperactivity Disorder Epidemiology Trends:
https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Attention-Deficit/Hyperactivity Disorder (ADHD) Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Attention-Deficit/Hyperactivity Disorder market or expected to be launched during the study period. The analysis covers the market share by Attention-Deficit/Hyperactivity Disorder drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Attention-Deficit/Hyperactivity Disorder Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities:
https://www.delveinsight.com/sample-request/attention-deficit-hyperactivity-disorder-adhd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Attention-Deficit/Hyperactivity Disorder (ADHD)Therapeutics Assessment
There are approx. 20+ key companies developing therapies for Attention Deficit Hyperactivity Disorder. Currently, Cingulate Therapeutics is leading the therapeutics market with its Attention Deficit Hyperactivity Disorder drug candidates in the most advanced stage of clinical development.

Some of the key Players in the Attention-Deficit/Hyperactivity Disorder Therapeutics Market Include:
• Cingulate Therapeutics
• Otsuka Pharmaceutical
• BioLite
• Mind Medicine
• Tris Pharma
• RespireRx Pharmaceuticals
• KemPharm
• Arbor Pharmaceuticals
• Ensysce Biosciences
• 3Z Pharmaceuticals
And Many More

Attention-Deficit/Hyperactivity Disorder (ADHD) Emerging and Marketed Drugs Covered in the Report Include:
• CTx-1301: Cingulate Therapeutics
• Centanafadine: Otsuka Pharmaceutical
• PDC-1421: BioLite, Inc.
And Many Others

Learn More About the Emerging Therapies & Key Companies in the Attention-Deficit/Hyperactivity Disorder Therapeutics Market:
https://www.delveinsight.com/sample-request/attention-deficit-hyperactivity-disorder-adhd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Attention-Deficit/Hyperactivity Disorder Competitive Intelligence Analysis
4. Attention-Deficit/Hyperactivity Disorder Market Overview at a Glance
5. Attention-Deficit/Hyperactivity Disorder Background and Overview
6. Attention-Deficit/Hyperactivity Disorder Patient Journey
7. Attention-Deficit/Hyperactivity Disorder Epidemiology and Patient Population
8. Attention-Deficit/Hyperactivity Disorder Treatment Algorithm, Current Treatment, and Medical Practices
9. Attention-Deficit/Hyperactivity Disorder Unmet Needs
10. Key Endpoints of Attention-Deficit/Hyperactivity Disorder Treatment
11. Attention-Deficit/Hyperactivity Disorder Marketed Products
12. Attention-Deficit/Hyperactivity Disorder Emerging Therapies
13. Attention-Deficit/Hyperactivity Disorder Seven Major Market Analysis
14. Attribute Analysis
15. Attention-Deficit/Hyperactivity Disorder Market Outlook (7 major markets)
16. Attention-Deficit/Hyperactivity Disorder Access and Reimbursement Overview
17. KOL Views on the Attention-Deficit/Hyperactivity Disorder Market.
18. Attention-Deficit/Hyperactivity Disorder Market Drivers
19. Attention-Deficit/Hyperactivity Disorder Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings:
https://www.delveinsight.com/sample-request/attention-deficit-hyperactivity-disorder-adhd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight -
• Mucopolysaccharidosis I Market
https://www.delveinsight.com/report-store/mucopolysaccharidosis-i-market

• Ocular Melanoma Market
https://www.delveinsight.com/report-store/ocular-melanoma-market

• Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market

• Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market

• Pars Plantis Market
https://www.delveinsight.com/report-store/pars-plantis-market

• Point of Care Glucose Testing Market
https://www.delveinsight.com/report-store/point-of-care-glucose-testing-market

• Respiratory Distress Syndrome Market
https://www.delveinsight.com/report-store/respiratory-distress-syndrome-market

• Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market

• Total Knee Arthroplasty Market
https://www.delveinsight.com/report-store/total-knee-arthroplasty-market

• Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight

• Traveler's Diarrhea Market
https://www.delveinsight.com/report-store/travelers-diarrhea-market

• Usher Syndrome Market
https://www.delveinsight.com/report-store/usher-syndrome-market

• Varicose Veins Market
https://www.delveinsight.com/report-store/varicose-veins-market

• Vulvodynia Market
https://www.delveinsight.com/report-store/vulvodynia-market

• Wide Neck Bifurcation Intracranial Aneurysms Market
https://www.delveinsight.com/report-store/wide-neck-bifurcation-intracranial-aneurysms-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.